For the best experience, use the Insights app.
Get the appGet
HealthDr Lal PathLabs has acquired a 70% stake in SN Genelab for ₹168 crore. This acquisition aims to enhance Dr Lal's genomics expertise and expand its advanced diagnostics portfolio, strengthening its position in the healthcare diagnostics sector.
Business Standard·14h ago
HealthMore than 2,000 Indian MBBS students studying in Kyrgyzstan face uncertainty as 13 medical colleges there reportedly failed to receive accreditation. This situation puts their medical education and future career prospects at risk, raising concerns among students and stakeholders about the recognition of their degrees and eligibility for medical practice.
Business Medical Dialogues·14h ago
HealthAuthorities conducted raids across 13 districts and found suspicious health supplements and nutraceuticals. The operation aims to ensure the safety and authenticity of health products available to consumers. Officials warn users to be cautious about the supplements they consume due to potential health risks from unverified products.
Samacharnama·14h ago
TechnologyThe WION Ai EDU Summit 2026 was held in Bengaluru on September 24, gathering policymakers, educators, and industry experts to explore AI's impact on education, learning, and future skills. Key speakers included Karnataka's School Education Minister Sri Madhu Bangarappa and Naganand Doraiswamy of Ideaspring Capital. Panels covered AI in business, education, and responsible innovation. The event ended with a Carnatic music performance by Vinay Sharva.
Afaqs·14h ago·Bengaluru
SportsOn September 25, Baranica Elangovan made history by winning a bronze medal for India in the women's pole vault final at the Asian Games. This achievement marks a significant milestone for India in this athletics event, entering her name into the record books.
News 18·14h ago
PoliticsThe U.S. Supreme Court has permitted the Department of Homeland Security to use the SAVE database for voter eligibility verification ahead of the 2026 midterm elections. This overturns a lower court's block on expanded use. Critics worry about record accuracy and false matches that could wrongly flag citizens. States may choose whether to use this federal resource for upcoming elections.
The Economic Times·14h ago
Business Standard·14h ago
Dr Lal PathLabs has acquired a 70% stake in SN Genelab for ₹168 crore. This acquisition aims to enhance Dr Lal's genomics expertise and expand its advanced diagnostics portfolio, strengthening its position in the healthcare diagnostics sector.
Tip: use ↑ / ↓ (or j / k) to move between stories.
